Matsuyama H, Matsubara N, Kazama H, Seto T, et al. Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan. BMC Cancer 2023;23:538.
PMID: 37308888